BIOTECH: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOTECH
Largest movements
- Receivables within one year +€252,749
up €252,749 (+131.9%), from €191,692 to €444,441
of which Trade receivables: +€149,031
- Cash -€106,835
down €106,835 (-78.1%), from €136,824 to €29,989
mainly Receivables within one year (-€252,749) and Other debts (-€48,798)
- Reserves +€96,186
up €96,186 (+69.8%), from €137,859 to €234,045
of which Distributable reserves: +€95,914
- Trade debts +€68,440
up €68,440 (+249.7%), from €27,411 to €95,851
- Other debts -€48,798
down €48,798 (-99.6%), from €49,000 to €202
- Debts after one year +€48,000
new in 2025: €48,000
- Current portion of long-term debt -€20,000
no longer reported in 2025 (was €20,000)
- Gross operating margin -€43,918
down €43,918 (-24.9%), from €176,101 to €132,183
- Taxes -€9,573
down €9,573 (-21.4%), from €44,795 to €35,222
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €328,516 | €474,430 | +€145,914 | +44.4% |
| Current assets | 29/58 | €328,516 | €474,430 | +€145,914 | +44.4% |
| Amounts receivable within one year | 40/41 | €191,692 | €444,441 | +€252,749 | +131.9% |
| Trade receivables | 40 | €190,781 | €339,812 | +€149,031 | +78.1% |
| Other amounts receivable | 41 | €911 | €104,629 | +€103,718 | +11385.1% |
| Cash at bank and in hand | 54/58 | €136,824 | €29,989 | -€106,835 | -78.1% |
| Total equity and liabilities | 10/49 | €328,516 | €474,430 | +€145,914 | +44.4% |
| Equity | 10/15 | €156,501 | €255,000 | +€98,499 | +62.9% |
| Contributions | 10/11 | €18,592 | €19,847 | +€1,255 | +6.8% |
| Capital | 10 | €18,592 | €19,847 | +€1,255 | +6.8% |
| Issued capital | 100 | €18,592 | €19,847 | +€1,255 | +6.8% |
| Reserves | 13 | €137,859 | €234,045 | +€96,186 | +69.8% |
| Non-distributable reserves | 130/1 | €1,859 | €1,985 | +€126 | +6.8% |
| Legal reserve | 130 | €1,859 | €1,985 | +€126 | +6.8% |
| Tax-exempt reserves | 132 | - | €146 | +€146 | |
| Distributable reserves | 133 | €136,000 | €231,914 | +€95,914 | +70.5% |
| Profit (loss) carried forward | 14 | €50 | €1,108 | +€1,058 | +2116.0% |
| Amounts payable | 17/49 | €172,015 | €219,430 | +€47,415 | +27.6% |
| Amounts payable after more than one year | 17 | - | €48,000 | +€48,000 | |
| Other amounts payable | 178/9 | - | €48,000 | +€48,000 | |
| Amounts payable within one year | 42/48 | €172,015 | €171,430 | -€585 | -0.3% |
| Current portion of amounts payable after more than one year | 42 | €20,000 | - | -€20,000 | |
| Trade debts | 44 | €27,411 | €95,851 | +€68,440 | +249.7% |
| Suppliers | 440/4 | €27,411 | €95,851 | +€68,440 | +249.7% |
| Taxes, remuneration and social security | 45 | €75,604 | €75,377 | -€227 | -0.3% |
| Taxes | 450/3 | €75,604 | €75,377 | -€227 | -0.3% |
| Other amounts payable | 47/48 | €49,000 | €202 | -€48,798 | -99.6% |
| Other operating charges | 640/8 | €434 | €438 | +€4 | +0.9% |
| Gross operating margin | 9900 | €176,101 | €132,183 | -€43,918 | -24.9% |
| Operating profit (loss) | 9901 | €175,667 | €131,745 | -€43,922 | -25.0% |
| Financial income | 75/76B | €390 | €1 | -€389 | -99.7% |
| Recurring financial income | 75 | €390 | €1 | -€389 | -99.7% |
| Financial charges | 65/66B | €3,619 | €2,506 | -€1,113 | -30.8% |
| Recurring financial charges | 65 | €3,619 | €2,506 | -€1,113 | -30.8% |
| Profit (loss) for the period before taxes | 9903 | €172,438 | €129,240 | -€43,198 | -25.1% |
| Income taxes | 67/77 | €44,795 | €35,222 | -€9,573 | -21.4% |
| Profit (loss) for the period | 9904 | €127,643 | €94,018 | -€33,625 | -26.3% |
| Profit (loss) for the period to be appropriated | 9905 | €127,643 | €94,018 | -€33,625 | -26.3% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.